164 results
10-K
2023 FY
EX-10.7
BTAX
Biostax Corp.
Annual report
15 Apr 24
8:32pm
10-K
2023 FY
EX-10.6
BTAX
Biostax Corp.
Annual report
15 Apr 24
8:32pm
8-K
EX-10.1
BTAX
Biostax Corp.
13 Sep 23
Departure of Directors or Certain Officers
5:16pm
8-K
EX-10.1
BTAX
Biostax Corp.
20 Apr 23
Entry into a Material Definitive Agreement
9:00am
8-K
EX-10.3
BTAX
Biostax Corp.
20 Apr 23
Entry into a Material Definitive Agreement
9:00am
8-K
EX-10.2
wv7s08o 67
20 Apr 23
Entry into a Material Definitive Agreement
9:00am
8-K
EX-10.2
uwatvc
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
ys9s 6efia
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
ntco77dp9f0pvysv
12 Oct 22
Entry into a Material Definitive Agreement
8:49am
8-K
EX-10.1
29q4kmy
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
8-K
EX-10.1
251328rt
7 Jul 22
Entry into a Material Definitive Agreement
5:27pm
8-K
EX-10.1
uq96wo65a
2 Jun 21
Other Events
9:00am